Secondary Prevention following CABG: Findings of a National Randomized Controlled Trial and Sustained Society-Led Incorporation into Practice

BACKGROUND: Despite evidence supporting the use of aspirin, B-blockers, ACE inhibitors, and lipid-lowering therapies in eligible patients, adoption of these secondary prevention measures following coronary artery bypass grafting (CABG) has been inconsistent. We sought to rigorously test on a nationa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Williams, Judson B., DeLong, Elizabeth R., Peterson, Eric D., Dokholyan, Rachel S., Ou, Fang-Shu, Ferguson, T. Bruce
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3683243/
https://ncbi.nlm.nih.gov/pubmed/21173357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.110.981068
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak